|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.120 EUR | -1.75% |
|
-5.08% | -23.81% |
| 06/07 | Laboratorio Erfo continues buyback, acquires 15,000 treasury shares | AN |
| 29/06 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 39.47L | 47.41L | 46.21L | 78.61L |
Direct | 6L | 5L | 7L | 9L | 10.88L |
Other | - | 5L | 6L | 6L | 7L |
Medical | - | 1L | 2L | 3L | 4L |
Revenues from Services | 1.12T | - | - | - | - |
Wholesale Sales Revenues | 40.72L | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 46.63L | 50.13L | 52.28L | 53.29L | 89.59L |
France | - | - | 8L | 9L | 9L |
Belgium | - | - | 2L | 2L | 2L |
Other (EU) | - | - | 5T | - | - |
Spain | 8T | 15.4T | 5.17T | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.75% | -5.08% | -12.50% | +14.52% | 1.11Cr | ||
| +0.13% | +4.41% | +48.19% | +163.20% | 1,06700Cr | ||
| +0.97% | +6.88% | +60.00% | +53.12% | 63TCr | ||
| -0.94% | +1.39% | +36.28% | +72.60% | 46TCr | ||
| +1.41% | +7.75% | +38.93% | +32.88% | 35TCr | ||
| +1.28% | +2.82% | +38.42% | +43.21% | 30TCr | ||
| +1.72% | +2.33% | +19.31% | +20.79% | 26TCr | ||
| +1.84% | -1.03% | -27.78% | -38.45% | 22TCr | ||
| +0.06% | +3.32% | +24.88% | +59.40% | 20TCr | ||
| +0.94% | -2.02% | +15.47% | +70.59% | 16TCr | ||
| Average | +0.90% | +0.85% | +24.12% | +49.18% | 36.44TCr | |
| Weighted average by Cap. | +0.86% | +1.95% | +37.75% | +78.43% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















